Instead of importing medical cannabis into Europe, two European countries, Denmark and Greece are investing in their own cannabis cultivations.
In Greece, growing medical cannabis has become a solution to help fix their unemployment and financial crisis. Greece plans to cultivate, process and export medical marijuana from a northern Greece town called Veroia, reports Independent. Investors from Canada, Kazakhstan, Poland, and Israel have already spent €400m (£352m) in its first round and now total investments have rose to €1.5bn.
In Denmark, where medicinal cannabis has become legal this year, Mads Pederson, dubbed the “Tomato King,” will be growing medicinal cannabis. The cultivation site will be in Odense or Denmark existing as a joint venture with the Canadian company Aurora, reported The Local Denmark.
“I think this is a chance that comes once in a lifetime. To work with a product that makes a difference,” he said to TV2. Pedersen’s company will invest 250 million kroner (33.5 million euros) into its facilities. The area will cover the size of 13 football pitches, according to TV2.
Denmark’s parliament has already legalized medicinal marijuana; which could be used to treat people with multiple sclerosis, spinal cord injuries, chronic pain and nausea and sickness secondary to chemotherapy.
But Denmark is faced with a problem synonymous with medical marijuana in America, which is a lack of research into the plants benefits.
“Despite decades of research into medicinal cannabis, we still don’t know for certain to what extent it works and for which patients,” chairperson of the Danish Medical Association Andreas Rudkjøbing told TV2. “We know nothing about dosage, length of treatment, side effects and long-term effects, whether there are precautionary rules in relation to other treatments or questions of addiction.”